
Organization · Private Equity
21 Invest
21 Invest is a European private equity firm based in Italy, specializing in mid-market buyout investments across sectors like healthcare, consumer goods, and technology. Founded in 1998, it focuses on driving growth in portfolio companies in Italy, France, and Poland.
Overview
What 21 Invest does
What 21 Invest is
21 Invest is a European private equity firm based in Italy, specializing in mid-market buyout investments across sectors like healthcare, consumer goods, and technology. Founded in 1998, it focuses on driving growth in portfolio companies in Italy, France, and Poland.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 1998
- Approximate age
- About 28 years
- Structured capabilities
- Funder
- Last reviewed
- March 26, 2026
Official channels
Find 21 Invest elsewhere
Open the official website or a supported primary organization account.
Capability profile
21 Invest as a funder
Investment thesis
21 Invest focuses on private equity investments in mid-market companies, primarily in the European market, with an emphasis on healthcare, consumer goods, and technology sectors.
Focus narrative
21 Invest invests in mid-market companies across various sectors, including healthcare, consumer goods, and technology. The firm targets companies in the growth stage, aiming to support their development and expansion. Their investment strategy is centered on creating value through operational improvements and strategic guidance.
Focus and fit
- Stages
- Growth Equity
- Sectors
- HealthcareConsumer
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- FMA Group
Portfolio context
Notable portfolio companies include FMA Group, which was recently exited to a strategic buyer, Synex; Ciesse Derma, acquired by Omega Pharma; Parkingo, acquired by 21 Invest; Delmont Imaging, acquired by Rocamed; Krupps, acquired by The Nice Kitchen; and Prosol, acquired by 21 Invest Healthcare.
Connected ecosystem
Continue from 21 Invest
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about 21 Invest
Upseed classifies 21 Invest under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.